L Visa
Overview
Explore the profile of L Visa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Plazas J, Arias-Martinez A, Lecumberri A, Martinez de Castro E, Custodio A, Cano J, et al.
ESMO Open
. 2022 Jun;
7(3):100514.
PMID: 35714478
Background: Recommendations for research articles include the use of the term sex when reporting biological factors and gender for identities or psychosocial or cultural factors. There is an increasing awareness...
2.
Pueyo-Periz E, Tellez-Marques C, Radosevic A, Morato O, Visa L, Ilzarbe L, et al.
Sci Rep
. 2022 May;
12(1):7486.
PMID: 35523857
To demonstrate the efficacy of radiofrequency for pancreatic stump closure in reducing the incidence of postoperative pancreatic fistula (POPF) in distal pancreatectomy (DP) compared with mechanical transection methods. Despite all...
3.
Viudez A, Carmona-Bayonas A, Gallego J, Lacalle A, Hernandez R, Cano J, et al.
Clin Transl Oncol
. 2019 Aug;
22(5):734-750.
PMID: 31385226
Background: The optimal duration of first-line chemotherapy for patients with advanced gastric cancer is unknown. Diverse clinical trials have proposed different strategies including limited treatment, maintenance of some drugs, or...
4.
Montagut C, Vidal J, Visa L
Ann Oncol
. 2018 Nov;
29(12):2280-2282.
PMID: 30423018
No abstract available.
5.
Girones R, Morilla I, Guillen-Ponce C, Torregrosa M, Paredero I, Bustamante E, et al.
Clin Transl Oncol
. 2018 Jan;
20(8):1087-1092.
PMID: 29327240
Introduction: Geriatric oncology (GO) is a discipline that focuses on the management of elderly patients with cancer. The Spanish Society of Medical Oncology (SEOM) created a Working group dedicated to...
6.
Custodio A, Carmona-Bayonas A, Jimenez-Fonseca P, Sanchez M, Viudez A, Hernandez R, et al.
Br J Cancer
. 2017 May;
116(12):1526-1535.
PMID: 28463962
Background: To develop and validate a nomogram and web-based calculator to predict overall survival (OS) in Caucasian-advanced oesophagogastric adenocarcinoma (AOA) patients undergoing first-line combination chemotherapy. Methods: Nine hundred twenty-four AOA...
7.
Vidal J, Muinelo L, Dalmases A, Jones F, Edelstein D, Iglesias M, et al.
Ann Oncol
. 2017 Apr;
28(6):1325-1332.
PMID: 28419195
Background: RAS assessment is mandatory for therapy decision in metastatic colorectal cancer (mCRC) patients. This determination is based on tumor tissue, however, genotyping of circulating tumor (ct)DNA offers clear advantages...
8.
Carmona-Bayonas A, Jimenez-Fonseca P, Custodio A, Sanchez Canovas M, Hernandez R, Pericay C, et al.
Gastric Cancer
. 2017 Apr;
21(1):96-105.
PMID: 28393278
Background: Although anthracycline-based triplets are one of the most widely used schedules to treat advanced gastric cancer (AGC), the benefit of including epirubicin in these therapeutic combinations remains unknown. This...
9.
Martin-Richard M, Gallego R, Pericay C, Garcia Foncillas J, Queralt B, Casado E, et al.
Invest New Drugs
. 2013 Oct;
31(6):1573-9.
PMID: 24077981
Background: Cisplatin and fluoropyrimidine (CF) are standard first- line treatment in advanced gastric cancer, but no second-line treatment has yet been established. We present a phase II study in which...
10.
Font C, Farrus B, Vidal L, Caralt T, Visa L, Mellado B, et al.
Ann Oncol
. 2011 Feb;
22(9):2101-2106.
PMID: 21325446
Background: The clinical significance of incidental venous thrombosis (IVT) is uncertain. The objective of this study was to compare the clinical characteristics and the outcome of cancer patients with IVT...